ABSTRACT. The dopamine D2 receptor (DRD2) is a crucial mediator for normal physiological processes. We cloned the pig DRD2 gene, investigated its distribution in tissues and identified polymorphisms by RT-PCR, quantitative real-time PCR and direct sequencing. Two Yorkshire pigs from Guangdong Academy of Agricultural Sciences (Guangzhou, China) were selected to clone the gene and investigate its expression; 16 individuals from four pig breeds (Yorkshire, Landrace, small-ear spotted, and Xinchang) were used to scan the variations. comprises five miRNA targeting sites, based on bioinformatics predictions. The pig DRD2 gene expresses predominantly in the pituitary gland, and then in oviducts and the hypothalamus. Both DRD2L and DRD2S mRNA were detected in cerebrum, cerebellum, hypothalamus, pituitary gland, back muscle, oviduct, uterus, and testis tissues; DRD2L was more abundant than DRD2S. The DRD2 gene is located on chromosome 9 and contains seven exons. Sixty-one different sequences were identified in this gene; among seven in the coding region, only one altered the encoded amino acid. These findings will help us understand the functions of the DRD2 gene in pigs.
INTRODUCTION
As a vital neurotransmitter in the central nervous system and an important hormone in the periphery, dopamine exerts widespread effects on the neuroendocrine secretion, behavioral and physiological functions, such as the control of movement, cognition and emotion (Blasi et al., 2009; Baskerville and Douglas, 2010; Korchounov et al., 2010) . Dopamine initiates the biological actions by binding to its receptors on the cell surface. At least 5 dopamine receptor subtypes have been identified so far, including the D1-class (DRD1 and DRD5) and D2-class (DRD2, DRD3 and DRD4) (Missale et al., 1998) . All of them are 7-transmembrane domain G protein-coupled receptors (GPCR), but show different ligand-binding characteristics, pharmacological properties and affinities to dopamine. In addition, the second messenger coupling and signal transduction pathways are different between D1-and D2-class receptors (Missale et al., 1998) .
DRD2 is a member of Class A GPCR family and possesses a long third intracellular loop with a short C-terminal (Missale et al., 1998; Hearn et al., 2002; Pivonello et al., 2007) . It is known that DRD2 can inhibit adenylyl cyclase activity through coupling with Gi protein and subsequently results in a decrease of intracellular cyclic AMP (Obadiah et al., 1999) . The DRD2 gene has been well studied in many species so far, i.e. its cloning and expression in mammals (Bunzow et al., 1988; Grandy et al., 1989; Myeong et al., 2000) , turkey (Schnell et al., 1999) , bullfrog (Nakano et al., 2010) , and fishes (Levavi-Sivan et al., 2005; Pasqualini et al., 2009) . Furthermore, different isoforms of DRD2 have been identified. In humans, alternative splicing generates two isoforms of DRD2, D2-short (DRD2S) and D2-long (DRD2L). They are different with an additional 29 amino acids in the third cytoplasmic loop, a region thought to govern the interaction with different Giα proteins (Dal Toso et al., 1989; Guiramand et al., 1995; Senogles et al., 2004) . Moreover, the expression pattern of these two isoforms is different. DRD2L is predominately expressed in postsynaptic regions, such as the pituitary gland and the striatum, whereas DRD2S is preferentially expressed in presynaptic regions, such as the hypothalamus and the substantia nigra (Sasabe and Ishiura, 2010) . It has been well documented that they had distinct functions in vivo. DRD2L mainly participates in postsynaptic dopaminergic transmission, whereas DRD2S acts as a presynaptic autoreceptor and inhibits DRD1 receptor-mediated functions (Usiello et al., 2000; Lindgren et al., 2003) . Ramírez et al. (2009) found that DRD2 might be involved in modulating the boar sperm capacitation and motility. Up to now, there is no report on pig DRD2 (pDRD2) gene. In the present study, RT-PCR was performed to clone pDRD2 cDNA from pig pituitary and hypothalamus. Then its tissue-specific expression was assessed by quantitative realtime PCR. Finally, polymorphisms were identified in its coding region, 3'UTR and partial introns.
MATERIAL AND METHODS

Animal samples and preparation of cDNA
Two Yorkshire pigs (one male and one female) of 120 d age were obtained from Guangdong Academy of Agricultural Sciences (Guangzhou, China). The tissues of pituitary and hypothalamus were used for cloning pDRD2 gene. A total of 20 tissues, including cerebrum, cerebellum, pituitary, hypothalamus, liver, spleen, heart, lung, kidney, abdominal fat, foreleg muscle, back leg muscle, back muscle, small intestine, stomach, lymph node, ovary, oviduct, uterus, and testis, were used for quantitative real-time PCR analysis of pDRD2 gene. All tissue samples were collected immediately after slaughter, frozen in liquid nitrogen, and stored at -80°C until RNA extraction.
Total RNA was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer instructions and then treated with RNAse free-DNAse I (Promega, Madison, WI, USA) to remove any contaminating genomic DNA. First-strand cDNA was synthesized using MMLV SuperScript II reverse transcriptase containing RNase inhibitor (Invitrogen, Carlsbad, CA, USA). The reaction was performed at 42°C for 40 min and then 99°C for 5 min.
A total of 16 individuals from four pig populations (4 from each), Yorkshire pig, Landrace pig, small-ear spotted pig, and Xinchang pig, were selected to scan the variations in the coding region, 3'UTR and partial intron of pDRD2 gene. Genomic DNA was extracted from ear samples. All animal procedures were handled in compliance with Law of the People's Republic of China on Animal Protection.
Cloning of the pig DRD2 cDNA
According to the predicted partial cDNA sequences of pig DRD2 gene (Ensembl ID: ENSSSCT00000016414), three pairs of primers (Table 1) were designed to obtain the full length cDNA. P1 and P2 were designed to amplify partial cDNA containing the start codon and the 3'UTR region containing the stop codon, respectively. P3 was designed to further verify the full-length cDNA sequence. The RT-PCR was performed with an Eppendorf Mastercycler (Eppendorf Limited, Hamburg, Germany). The amplification conditions were as follows: 94°C for 5 min, 30 cycles of 94°C for 30 s, n °C (AT shown in Table 1 ) for 1 min and 72°C for 1 min, then completed by 72°C for 10 min. The amplified fragment of the predicted size was subcloned into the pMD18-T vector (TaKaRa Biotechnology Co., Ltd., Dalian, China), and then sequenced on automated sequencers ABI 3700 (Invitrogen Biotechnology Co., Ltd., Shanghai, China).
Quantitative real-time PCR
The expression patterns of pig DRD2 gene in each tissue were quantified by quantitative real time PCR using primer P4 (Table 1) . Primer P5 was designed to amplify the pig β-actin gene (GenBank ID: DQ845171.1), which was used as internal positive control ( Table  1) . Amplification was run on the ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA, USA) under the following conditions: 95°C for 3 min; 40 cycles of 95°C for 30 s, 61°C for 30 s and 72°C for 40 s. For each sample, the amplification of DRD2 gene was run in parallel with the β-actin gene. After amplification, dissociation curves were observed to verify the specificity of the assays and one representative product for each gene was sequenced to confirm the correct amplification of fragments. The whole experiment was performed in triplicate. The relative mRNA expression in each tissue was obtained by the 2 -ΔΔCt method (Livak and Schmittgen, 2001) . All data were expressed as means ± standard error means.
Semiquantitative RT-PCR analysis of DRD2L and DRD2S expression
The relative expression of pDRD2L and pDRD2S was investigated by RT-PCR using P6, which generated a 247-or 160-bp fragment. The PCR reaction program is described above. The amplified fragments were separated by non-denatured polyacrylamide gel (16%, w/v) in 1X Tris-boric acid-EDTA buffer (pH = 8.0). Gels were stained with silver nitrate. Tissues with high or moderate mRNA levels of DRD2 (DRD2L and DRD2S), including cere- brum, cerebellum, hypothalamus, pituitary, back leg muscle, back muscle, oviduct, uterus, and testis, were used to compare DRD2L and DRD2S expression.
Genomic structure and polymorphism analysis of the pig DRD2 gene
The obtained cDNA sequences of the DRD2 gene were used in the draft pig genomic sequence database (http://genome.ucsc.edu/cgi-bin/hgBlat, 2009.9) to reveal its genomic structure. According to genomic sequences, 7 pairs of primers (E1 to E7, shown in Table 1 ) were synthesized to identify polymorphisms of this gene in the coding region. PCR products amplified from the 16 pigs were sent to sequence directly by the Invitrogen Biotechnology Co. Ltd (Shanghai, China). Forward and reverse reactions were both carried out to avoid false positives. Then all sequences were used to identify the variations of pig DRD2 gene.
Data analyses
The prediction of miRNA binding sites for the 574-bp deletion in the pDRD2S 3'UTR was performed by RNAhybrid2.2 (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/) and filtered with RNA22 (http://cbcsrv.watson.ibm.com/rna22_targets.html) (Kruger and Rehmsmeier, 2006) . Transmembrane helices prediction was performed with TMHMM 2.0 (http://genome.cbs.dtu.dk/services/TMHMM-2.0). The amino acid sequences of DRD2 in other species used for the homology analysis were retrieved from the GenBank ® database. The GenBank ® IDs for humans, mouse, cattle, dog, turkey and chicken are NP_000786.1, NP_034207.2, NP_776468.1, NP_001003110.1, AAD03818.1, and ABY28377.1, respectively. Amino acid sequence alignments and homology analysis were accomplished by ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
RESULTS
The full-length cDNA of the pig DRD2 gene
The cDNA sequence of the pig DRD2 gene was deduced from two independent clones and the full sequence was further verified by the clone from primer P3. Two different transcripts, pDRD2L and pDRD2S, were identified and the obtained sequences had been submitted to NCBI database (GenBank ® ID: JF412702 and JF412703). The obtained pDRD2L and pDRD2S are 2489 and 1828 bp long, produced by the presence or absence of an 87-bp fragment in exon 5 and a 574-bp fragment in the 3'UTR. pDRD2L contains a 1332-bp open reading frame (ORF) flanked by a 14-bp 5'UTR (incomplete) and a 1,143-bp 3'UTR, whereas pDRD2S contains a 14-bp 5'UTR, a 1245-bp ORF, and a 569-bp 3'UTR (Figure 1 ). pDRD2L and pDRD2S encode a 444-and 415-amino acid protein with an expected molecular mass of 50.7 and 47.4 kDa, respectively. Protein sequence analysis suggests that pDRD2 contains seven putative transmembrane domains (TMs). The sequences within TM regions are highly conserved among species, whereas the third intracellular loop is the most variable region (Supplementary Figure 1) . pDRD2 shows high identity to its counterpart in humans (97.1%), mouse (96.4%), cattle (98.2%), dog (98.0%), turkey (79.1%) and chicken (80.1%). Changes of miRNA binding sites by the 574-bp deletion in the 3'UTR Online prediction showed that five possible binding sites for five miRNAs were observed in the 574-bp segment, which was deleted in the 3'UTR of the pig DRD2S gene. These miRNAs are ssc-miR-744, ssc-miR-339-5p, ssc-miR-1307, ssc-miR-1271, and ssc-miR-328.
Tissue-specific expression of the pig DRD2 gene
The pig DRD2 gene is expressed at different level in different tissues (Figure 2) . The pituitary tissue has the highest mRNA level, which is about 3.8 times higher than oviduct. Moderate expression levels of DRD2 mRNA were observed in hypothalamus, uterus, back leg muscle, cerebellum, as well as in back muscle. Low or trace quantities were found in other tissues such as cerebrum, heart, liver, spleen, lung, kidney, abdominal fat, foreleg muscle, small intestine, stomach, lymph node, ovary, and testis. In the pituitary gland and foreleg muscle, the mRNA level in male is relatively lower than female (Supplementary Figure 2) . -ΔΔCt value (mean ± SE), respectively. Each sample was repeated three times.
Differential expression of DRD2L and DRD2S in pig tissues
The mRNA of both DRD2L and DRD2S were detected in most of pig tissues that we examined, including cerebrum, cerebellum, hypothalamus, pituitary, back leg muscle, back muscle, oviduct, uterus, and testis. The expression of DRD2L is more abundant than that of DRD2S, even though the ratio between the long and short isoforms seems to be different among different tissues (Figure 3 ). DRD2L exhibited high or moderate mRNA levels in all tissues examined. DRD2S was expressed mainly in cerebrum, cerebellum, hypothalamus, pituitary, and uterus followed by oviduct and testis. In female, DRD2S was not detected in back leg muscle (Figure 3 ).
Genomic characterization of the pig DRD2 gene
Alignment showed that pig DRD2 gene was located at 40,051,792 -40,066,192 nt of chromosome 9 and spanned approximately 14,400 bp. It contains 7 exons with nucleotide sizes of 318, 110, 137, 191, 87, 328, and 194 bp, respectively . The longest intron is intron 1 (5030 bp) and the shortest one is intron 4 (938 bp). All the consensus sequences of the splice donor and acceptor follow the "GT-AG" rule ( Figure 4) . 
Polymorphisms of the pig DRD2 gene
Fifty-one SNPs, 9 indel variations and a C microsatellite were identified in 4868 bp sequence of the pig DRD2 gene covering the entire coding region, 3'UTR region, and part of intron region (Table 2 ). The polymorphism density is one SNP per 80 bp. In these 61 variations, 7 SNPs are located in the coding region and 14 variations in the 3'UTR. The average density for the coding region and the 3'UTR is one SNP per 190 bp and one per 82 bp, respectively. Among the 7 SNPs in the coding region, only one SNP (T40064902A, Phe390Tyr) is a non-synonymous mutation which is located in transmembrane domain VI (Table 3) . Three synonymous polymorphisms, G40052148A, C40057247T, and G40058375A, occur in transmembrane domain II, III, and IV, respectively. The other three variations, C40057199T, G40060801A, and T40062532C, are present in the extracellular domain or the third intracellular loop of DRD2. The variations are based on chromosome 9 of the pig genomic sequences released in November 2009 (http:// genome.ucsc.edu/). 
DISCUSSION
The DRD2 gene is generally alternative spliced in mammals. Two distinct DRD2-encoding mRNA, DRD2L and DRD2S, have been characterized in many mammals (Montmayeur et al., 1991; Myeong et al., 2000) . Moreover, a novel transcript (DRD2 Longer ) of this gene, with two extra codons in exon 6 than DRD2L, was discovered from the human brain (Seeman et al., 2000) . Although DRD2 Longer was not found in this study, two other variants, DRD2L and DRD2S, were characterized in pig. The short isoform (pDRD2S) was generated due to an 87-bp deletion in exon 5 and a 574-bp deletion in 3'UTR caused by alternative splicing, which resulted in a 29-amino acid absence in the third intracellular loop. This might lead to DRD2S and DRD2L coupling with distinct subtypes of Giα proteins (Senogles et al., 2004) . Moreover, the change of possible miRNA binding sites targeting the deleted 574 bp suggests that this segment might affect gene expression at posttranslational and/or posttranscriptional level, which still needs further investigation. The sequence alignment showed that pDRD2 shared the basic structural features with that of other species, possessing an N-terminal extracellular domain, 7 TMs, a large third intracellular loop and a short C-terminal intracellular domain (Pivonello et al., 2007) . In humans, rat and mouse, the DRD2 gene contains 8 exons, and exon 1 is far away from exon 2 (O' Malley et al., 1990; Mack et al., 1991; Taylor et al., 2006) (Figure 5 ). However, only 7 exons were found in pig, which was similar to that of cattle and dog (Myeong et al., 2000; Zimin et al., 2009) . Whether there is an extra exon in the upstream of pig DRD2 gene still requires further study. Figure 5 . The genomic organization and alternative splicing of DRD2 gene among humans, mouse, dog and pig. Boxes in gray indicated exons and numbers inside represented the nucleotide sizes (bp) for each exon. "-//-" indicated that there existed partial unknown sequences according to the UCSC BLAT search (http://genome.ucsc. edu/cgi-bin/hgBlat). Alternative splicing, which generated two isoforms with an 87-bp difference, occurred in the same position of DRD2 gene among humans, mouse and dog. However, in the pig DRD2 gene, alternative splicing also occurred in the 3'UTR and an additional 574-bp deletion appeared in the short isoform.
In mammals such as humans and mouse, DRD2 expresses high mRNA level in pituitary and low level in cortex (Montmayeur et al., 1991; Neve et al., 1991) . Meanwhile, the canine DRD2 showed the moderate expression in thalamus and negligible in cerebral cortex (Myeong et al., 2000) . In accordance, the pig DRD2 gene predominantly expresses in pituitary and lowly in the cerebrum. The fact that the DRD2 gene preferentially expresses in pituitary or hypothalamus tissues in most species is probably related to its important function as a mediator for dopamine. Previous studies in humans have demonstrated that DRD2L was preferentially expressed in postsynaptic regions such as pituitary, whereas DRD2S preferred to express in presynaptic regions such as hypothalamus (Usiello et al., 2000; Sasabe and Ishiura, 2010) . However, in this study, no obvious difference for both pDRD2L and pDRD2S expression was found between hypothalamus and pituitary tissues. In turkey, even though it is surprising that the DRD2S could not be detected in any of the peripheral tissues, the fact that both DRD2L and DRD2S are widely distributed in cerebellum, hypothalamus, and pituitary tissues, is consistent with our results (Schnell et al., 1999) .
In this study, abundant polymorphisms were observed in pig DRD2 gene. Wiedmann et al. (2008) reported that the SNP density in pigs was higher than 1:370 bp. Here the SNP frequency of the pDRD2 gene is one per 80 bp, similar to previous results before correction for sample size (Jungerius et al., 2005) . Structure analysis of the human DRD2 showed that, Asp114 in TM III and Phe390 in TM VI were essential for its binding to dopamine (Shi and Javitch, 2002; Kalani et al., 2004) . In this study, the mutation Phe390Tyr might have altered the affinity of pig DRD2 to its ligand. Duan et al. (2003) found that synonymous variations in the human DRD2 can affect mRNA stability and synthesis of the receptor. Although the other 6 mutations in the coding region of pDRD2 were synonymous SNPs, they might have potential effects on regulating gene expression via the changes of mRNA stability. On the other hand, some intronic SNPs of DRD2 could modify mRNA expression and splicing and were related with diseases or traits (Zhang et al., 2007; Moyer et al., 2011) . In this study, we also observed many mutations in the intron region of the pDRD2 gene. As a whole, the real effects of all these polymorphisms identified by this study still require further investigation.
In conclusion, the full length cDNA and two variant transcripts of the pig DRD2 gene were obtained, and it comprised 7 exons and 6 introns. The pDRD2 gene was predominantly expressed in pituitary tissue and then in oviduct. Both DRD2L and DRD2S mRNA were detected in cerebrum, cerebellum, hypothalamus, pituitary, back muscle, oviduct, uterus and testis, and among them, DRD2L was more abundant than DRD2S. In addition, a total of 61 variations were found.
